tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
IMRX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-EarningsIMRX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
19d ago
3 Best Stocks to Buy Now, 11/3/2025, According to Top Analysts
Premium
Market News
3 Best Stocks to Buy Now, 11/3/2025, According to Top Analysts
26d ago
Apple upgraded, Comcast downgraded: Wall Street’s top analyst calls
Premium
The Fly
Apple upgraded, Comcast downgraded: Wall Street’s top analyst calls
29d ago
Immuneering Announces Public Offering to Raise $164.1M
PremiumCompany AnnouncementsImmuneering Announces Public Offering to Raise $164.1M
2M ago
Immuneering price target raised to $30 from $21 at Oppenheimer
Premium
The Fly
Immuneering price target raised to $30 from $21 at Oppenheimer
2M ago
Immuneering 18.96M share Spot Secondary priced at $9.23
Premium
The Fly
Immuneering 18.96M share Spot Secondary priced at $9.23
2M ago
Immuneering appoints Schall as Chairman of the Board
PremiumThe FlyImmuneering appoints Schall as Chairman of the Board
2M ago
Immuneering’s Strategic Advances and Positive Outlook Boost Buy Rating and Price Target
Premium
Ratings
Immuneering’s Strategic Advances and Positive Outlook Boost Buy Rating and Price Target
3M ago
Immuneering to announce updated data from Phase 2a trial of Atebimetinib + mGnP
Premium
The Fly
Immuneering to announce updated data from Phase 2a trial of Atebimetinib + mGnP
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100